Day 1: Introduction CRC, Wnt signalling pathway and targets, Stem cell development Flashcards
HC 01, 02, 03, 04
TNM staging in CRC: T staging (tumor size)
T1: Tumor only in inner layer of bowel
T2: Tumor into muscle layer of bowel wall
T3: Tumor has grown into outer lining of bowel wall
T4: Tumor has grown through outer lining and may have grown into other structures
TNM staging CRC: N and M staging (lymph nodes and metastasis)
N0: No lymph nodes containing cancer cells
N1: 1-3 lymph nodes close to the bowel contain cancer cells
N2: 4+ lymph nodes close to the bowel contain cancer cells
M0: No metastasis
M1: Metastases
Cancer stages and CRC treatment strategies
Other kind of staging for overall tumor
- Stage 1: Surgery
- Stage 2: Surgery and sometimes adj. Chemo
- Stage 3: Surgery and Chemo
- Stage 4: Chemo and targeted therapy and sometimes surgery (bad prognosis)
Histology plate with cancer with a lot of stroma means?
More chance of metastasis
Different cancers and relative expression in character?
Can differ
How long does it take to develop adenomas in colon? And cancer?
5-20 years for adenoma
From there: 5-15 years to cancer
10-35 years until cancer total
Why does the development of the cancer take so long?
Multi-hit model
Carcinogenesis promotion by SV40 virus
Contains LT which inhibits p53 and RB in the cell (cell cycle regulators)
> loss cell cycle control for short time
> induce senescence programs after short period of unregulated cell proliferation
> fast exponential growth is then stopped
How is senescence induced in rapid proliferating cells?
Short telomers
Gene and protein for extending telomers in stem cells and mutated cells
Telomerase (in human: hTERT gene)
> a proto-oncogene, should not get gain-of-function
> used in stem cells
LT + TERT hits in cells (mutations/gains)
Longer proliferation than only LT, but still stops
> control regained
LT + TERT mutation + Ras mutation
Can grow in vitro and in vivo
> Ras mutation > classic oncogene
Ras mutation
Ras induces signalling for proliferation
> mutation: continuously active
How many mutations in CRC (colorectal cancer)?
1500-1.5 mutations
> majority mutations is for non-functional DNA (however, noncoding has functions)
Six Hallmarks of Cancer
-Self-sufficiency in growth signals
-Insensitive to antigrowth signals
-Tissue invasion and metastasis
-Limitless replicative potential
-Sustained angiogenesis
-Resist apoptosis
Telomerase mutation: for which hallmark of cancer?
Limitless replicative potential
Ras mutation hallmark
Self-sufficiency in growth signals
Vogelgram for CRC
Normal epithelium
> Loss of APC
Hyperplastic epithelium
>
Early adenoma
> Activation KRAS
Intermediate adenoma
> Loss Smad4
Late adenoma
> Loss p53
Carcinoma
> invasion
Invasive metastasis
How many hit model is the Vogelgram for CRC?
4-hit model
4-hit model order of mutations. Is this rigid
APC>KRAS>Smad4>p53
-It can vary
-When early inflammation: p53 before APC
Ras mutation and 17p loss (p53 mutation) in early, intermediate and late adenoma
Early: not a lot of Ras mutation and 17p loss
Intermediate: a lot of Ras mutation but not a lot of 17p loss
Late: both high
> first Ras mutation, then p53 loss
Familial adenomatous polyposis (FAP) and gene involved
-On early age: development many adenomas in colon (benign)
-100% penetrance of colon cancer: develops always
> other malignancies can develop
-APC locus involved
> Chromosome 5 mutation
Juvenile polyposis and gene involved
-Juvenile polyp formation (adenomas)
-Familial syndrome: early onset
-Caused when loss BMP signalling
> Mutation BMPR1 gene
> Mutation SMAD4 gene
BMP signalling result for colon cancer development
Induce differentiation in intestine: block colon cancer growth
The 4 hits from the 4-hit-model and the related Hallmarks of cancer
- APC: Self-sufficiency in growth signals
- KRAS: Self-sufficiency in growth signals
- SMAD4: Insensitivity to anti-growth signals
- P53: Evading apoptosis
4-hit-model and in vitro colon cancer in organoids
-APC CRISPR mutation, and also P53, KRAS and SMAD4 mutations induced.
> only growth when all 4 mutations in organoids
> three-fold mutation: fast proliferation which is halted later
What characteristics (name, not list) does cancer need to be called that?
Hallmarks of cancer
HC02: Identification INT1
Retroviral-induced cancer > insertion DNA and overactive promotor near oncogene to make them overactive > more expression oncogene and other nearby genes
> Common integration site in retroviral-induced cancer: INT1
Retroviral life cycle
Infection cell with RNA
> Reverse transcription
> Insertion into chromosomal DNA
> Transcription and translation > assembly and budding of the virus.
Drosophila born without wings
Defect in the Wg (wingless) gene > defect in segmentation (polarity) and development
> same phenotype with deficient Wg and Tcf
The INT1 region and Wg gene both relate to the gene
Wnt
How many types of Wnt genes
Around 17
Functions Wnt
-Development and stem cell biology
-Cell proliferation
Where expression Wnt?
Wnt has different specialized functions, in tissues for neuronal development, segementation, proliferation
Where is Wnt located in the 4-hit model (the Vogelgram)?
First hit: at the loss of APC
Result loss of APC
Formation adenomas > hyperproliferation
CRC patients without APC mutation mostly have a mutated …
beta-catenin
APC mutations and Beta-catenin mutations occur …
Mutually exclusive
> hardly co-occur
> same pathway: no advantage for both mutated (no selective pressure in cancer development)
Reasons for mutually exclusive mutations
-Same pathway
-Toxic together which leads to cell death
Discovery Beta-catenin target
TCF-1 (a TF highly expressed in T-lymphocytes and important for intestinal epithelium)
> Luciferase expression test, TCF-b-catenin complex activates expression and fluorescence.
Which part of APC is mutated in cancer?
b-catenin binding domain
Blocking beta-catenin pathway which is active in cancer in vitro by addition:
APC is lost in cancer
> add wild-type (WT) APC > no expression Luciferase
APC is an inhibitor of …
b-catenin induced transcription
APC mutation in cancer
No inhibition of beta-catenin: no more control
> continuous b-catenin-TCF induced transcrption
> gene programs for cell proliferation
> hyperproliferation
APC binding function, and what if this is disrupted?
APC can bind b-catenin
> truncation of b-catenin at binding region for APC > no inhibition of the b-catenin-TCF transcription program: hyperproliferation.
Mutations of beta-catenin
On specific locations on N-terminal serines or threonines
> No phosphorylation of b-catenin
> target of kinases, regulation b-catenin
Which kinases can phosphorylate b-catenin
GSK3b and CK1
> on N-terminal residues
> not in TCF binding site (or APC binding site ofc)
> different role in regulating b-catenin
Effect high expression of Wnt
Wnt signalling: APC blocked (destruction complex blocked), b-catenin released to bind TCF and activate target genes